share_log

葫芦娃(605199.SH):全资子公司收到药品GMP符合性检查结果

Hainan Huluwa Pharmaceutical Group (605199.SH): The wholly-owned subsidiary received the Pharmaceutical GMP compliance inspection results.

Gelonghui Finance ·  Dec 31, 2024 17:03

Gelonghui December 31丨Hainan Huluwa Pharmaceutical Group (605199.SH) announced that its wholly-owned subsidiary Guangxi Weiwei Pharmaceutical Co., Ltd. (hereinafter referred to as "Guangxi Weiwei") recently received the "Notification of Pharmaceutical GMP Compliance Inspection Results" issued by the Guangxi Zhuang Autonomous Region Pharmaceutical Supervision and Administration Bureau. The company has acquired the pediatric phlegm-reducing cough granules from Guangxi Wuzhou Sanjian Pharmaceutical Co., Ltd. (Announcement No.: 2023-004) and has passed the GMP compliance inspection after completing the holder change.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment